Shaochun Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shaochun Yang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Jianguo Zhong
Neurosurgery Department of the First Affiliated Hospital of Gannan Medical University, Ganzhou, China
3 shared publicationsGuanfu Ding
Department of Neurosurgery Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, People's Republic of China
2 shared publicationsRenhui Yi
Neurosurgery Department of the First Affiliated Hospital of Gannan Medical University, Ganzhou, China
2 shared publicationsYu Jiang
The First DongGuan Affiliated Hospital of Guangdong Medical University, Dongguan, China
2 shared publicationsAmy Ockleton
Peninsula Medical School, University of Plymouth, Plymouth PL6 8BU, UK
1 shared publicationBoris Krischek
Department of Neurosurgery, University Hospital of Cologne, Cologne, Germany
1 shared publication
Latest Publications
- Open Access
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1729651
Misdiagnosis of rivaroxaban-associated multiple intracranial hemorrhages as intracranial metastatic tumor: a case report
Rivaroxaban, a direct oral anticoagulant (DOAC), has emerged as a first-line therapy for the prevention and treatment of thromboembolic diseases, such as stroke in atrial fibrillation, due to its consistent anticoagulant effect. Nevertheless, vigilance remains imperative concerning its potential adverse reactions, particularly rare imaging manifestations that may result in misdiagnosis. This report details an 88-year-old female patient with atrial fibrillation who experienced multiple intracranial hemorrhages approximately 20 days after commencing rivaroxaban therapy. Initial contrast-enhanced cranial magnetic resonance imaging revealed multiple intracranial nodules with ring enhancement and edema, leading to a misdiagnosis of “multiple intracranial metastatic tumors with hemorrhage.” Following the discontinuation of rivaroxaban, no antitumor therapy was administered; only antihypertensive therapy and symptomatic management were provided. Dynamic follow-up revealed gradual lesion shrinkage, with partial resolution several months post-discontinuation. The case was ultimately diagnosed as rivaroxaban-associated multiple intracranial cerebral hemorrhages. This case highlights that rivaroxaban-associated intracranial hemorrhage may present as rare multiple nodular lesions. Their imaging characteristics can easily be confused with those of intracranial metastatic tumors. Clinical diagnosis requires comprehensive evaluation incorporating medication history, dynamic imaging follow-up, and lesion progression to avoid misdiagnosis and overtreatment. Additionally, for elderly patients with multiple comorbidities, the prescription of DOACs should include individualized evaluation to optimize dosage selection and monitoring strategies.
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1729651
Open AccessMisdiagnosis of rivaroxaban-associated multiple intracranial hemorrhages as intracranial metastatic tumor: a case report
Rivaroxaban, a direct oral anticoagulant (DOAC), has emerged as a first-line therapy for the prevention and treatment of thromboembolic diseases, such as stroke in atrial fibrillation, due to its consistent anticoagulant effect. Nevertheless, vigilance remains imperative concerning its potential adverse reactions, particularly rare imaging manifestations that may result in misdiagnosis. This report details an 88-year-old female patient with atrial fibrillation who experienced multiple intracranial hemorrhages approximately 20 days after commencing rivaroxaban therapy. Initial contrast-enhanced cranial magnetic resonance imaging revealed multiple intracranial nodules with ring enhancement and edema, leading to a misdiagnosis of “multiple intracranial metastatic tumors with hemorrhage.” Following the discontinuation of rivaroxaban, no antitumor therapy was administered; only antihypertensive therapy and symptomatic management were provided. Dynamic follow-up revealed gradual lesion shrinkage, with partial resolution several months post-discontinuation. The case was ultimately diagnosed as rivaroxaban-associated multiple intracranial cerebral hemorrhages. This case highlights that rivaroxaban-associated intracranial hemorrhage may present as rare multiple nodular lesions. Their imaging characteristics can easily be confused with those of intracranial metastatic tumors. Clinical diagnosis requires comprehensive evaluation incorporating medication history, dynamic imaging follow-up, and lesion progression to avoid misdiagnosis and overtreatment. Additionally, for elderly patients with multiple comorbidities, the prescription of DOACs should include individualized evaluation to optimize dosage selection and monitoring strategies.
- Open Access
- 31 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 168 (Pt 1) , 115734
Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential
- 31 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 168 (Pt 1) , 115734
Open AccessSmall-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential
- Open Access
- 12 November 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-14
Diagnostic and predictive value of radiomics-based machine learning for intracranial aneurysm rupture status: a systematic review and meta-analysis
Currently, the growing interest in radiomics within the clinical practice has prompted some researchers to differentiate the rupture status of intracranial aneurysm (IA) by developing radiomics-based machine learning models. However, systematic evidence supporting its performance remains scarce. The purpose of this meta-analysis and systematic review is to assess the diagnostic performance of radiomics-based machine learning for the early detection of IA rupture and to offer evidence-based recommendations for the application of radiomics in this area. PubMed, Cochrane, Embase, and Web of Science databases were searched systematically up to March 2, 2024. The Radiomics Quality Score (RQS) was employed to assess the risk of bias in all included primary studies. We separately discussed the diagnostic or predictive performance of machine learning for IA rupture status based on task type (diagnosis or prediction). We finally included 15 original studies covering 9,111 IA cases. In the validation cohort, radiomics demonstrated a sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, as well as SROC curve of 0.84 (95% CI: 0.76–0.90), 0.82 (95% CI: 0.77–0.86), 4.7 (95% CI: 3.7–5.8), 0.19 (95% CI: 0.13–0.29), and 24 (95% CI: 15–40), respectively, for the diagnostic task of aneurysm rupture status. Only 2 studies (3 models) addressed predictive tasks, with sensitivity and specificity ranging from 0.77 to 0.89 and from 0.69 to 0.87, respectively. Radiomics-based machine learning exhibits promising accuracy for early identification of IA rupture status, whereas evidence for its predictive capability is limited. Further research is needed to validate predictive models and provide insights for developing specialized strategies to prevent aneurysm rupture.
- 12 November 2024
- Published by Springer Nature in Neurosurgical Review
- Vol. 47 (1) , 1-14
Open AccessDiagnostic and predictive value of radiomics-based machine learning for intracranial aneurysm rupture status: a systematic review and meta-analysis
Currently, the growing interest in radiomics within the clinical practice has prompted some researchers to differentiate the rupture status of intracranial aneurysm (IA) by developing radiomics-based machine learning models. However, systematic evidence supporting its performance remains scarce. The purpose of this meta-analysis and systematic review is to assess the diagnostic performance of radiomics-based machine learning for the early detection of IA rupture and to offer evidence-based recommendations for the application of radiomics in this area. PubMed, Cochrane, Embase, and Web of Science databases were searched systematically up to March 2, 2024. The Radiomics Quality Score (RQS) was employed to assess the risk of bias in all included primary studies. We separately discussed the diagnostic or predictive performance of machine learning for IA rupture status based on task type (diagnosis or prediction). We finally included 15 original studies covering 9,111 IA cases. In the validation cohort, radiomics demonstrated a sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, as well as SROC curve of 0.84 (95% CI: 0.76–0.90), 0.82 (95% CI: 0.77–0.86), 4.7 (95% CI: 3.7–5.8), 0.19 (95% CI: 0.13–0.29), and 24 (95% CI: 15–40), respectively, for the diagnostic task of aneurysm rupture status. Only 2 studies (3 models) addressed predictive tasks, with sensitivity and specificity ranging from 0.77 to 0.89 and from 0.69 to 0.87, respectively. Radiomics-based machine learning exhibits promising accuracy for early identification of IA rupture status, whereas evidence for its predictive capability is limited. Further research is needed to validate predictive models and provide insights for developing specialized strategies to prevent aneurysm rupture.
- Open Access
- 12 November 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 287, 117311
Combining mendelian randomization analysis and network toxicology strategy to identify causality and underlying mechanisms of environmental pollutants with glioblastoma: A study of Methyl-4-hydroxybenzoate
- 12 November 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 287, 117311
Open AccessCombining mendelian randomization analysis and network toxicology strategy to identify causality and underlying mechanisms of environmental pollutants with glioblastoma: A study of Methyl-4-hydroxybenzoate
- Open Access
- 24 July 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (1) , 704-705
Multiple brain abscesses caused by Nocardia farcinica: Report of a rare case
- 24 July 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (1) , 704-705
Open AccessMultiple brain abscesses caused by Nocardia farcinica: Report of a rare case
- Open Access
- 20 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (42) , e35490
Research progress and perspectives of N-methyl-D-aspartate receptor in myocardial and cerebral ischemia-reperfusion injury: A review
There is an urgent need to find common targets for precision therapy, as there are no effective preventive therapeutic measures for combined clinical heart-brain organ protection and common pathways associated with glutamate receptors are involved in heart-brain injury, but current glutamate receptor-related clinical trials have failed. Ischemia-reperfusion injury (IRI) is a common pathological condition that occurs in multiple organs, including the heart and brain, and can lead to severe morbidity and mortality. N-methyl-D-aspartate receptor (NMDAR), a type of ionotropic glutamate receptor, plays a crucial role in the pathogenesis of IRI. NMDAR activity is mainly regulated by endogenous activators, agonists, antagonists, and voltage-gated channels, and activation leads to excessive calcium influx, oxidative stress, mitochondrial dysfunction, inflammation, apoptosis, and necrosis in ischemic cells. In this review, we summarize current research advances regarding the role of NMDAR in myocardial and cerebral IRI and discuss potential therapeutic strategies to modulate NMDAR signaling to prevent and treat IRI.
- 20 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (42) , e35490
Open AccessResearch progress and perspectives of N-methyl-D-aspartate receptor in myocardial and cerebral ischemia-reperfusion injury: A review
There is an urgent need to find common targets for precision therapy, as there are no effective preventive therapeutic measures for combined clinical heart-brain organ protection and common pathways associated with glutamate receptors are involved in heart-brain injury, but current glutamate receptor-related clinical trials have failed. Ischemia-reperfusion injury (IRI) is a common pathological condition that occurs in multiple organs, including the heart and brain, and can lead to severe morbidity and mortality. N-methyl-D-aspartate receptor (NMDAR), a type of ionotropic glutamate receptor, plays a crucial role in the pathogenesis of IRI. NMDAR activity is mainly regulated by endogenous activators, agonists, antagonists, and voltage-gated channels, and activation leads to excessive calcium influx, oxidative stress, mitochondrial dysfunction, inflammation, apoptosis, and necrosis in ischemic cells. In this review, we summarize current research advances regarding the role of NMDAR in myocardial and cerebral IRI and discuss potential therapeutic strategies to modulate NMDAR signaling to prevent and treat IRI.
- Open Access
- 4 July 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (11) , 5001-5002
Atrial fibrillation-caused cerebral and splenic infarction: A case report
- 4 July 2023
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (11) , 5001-5002
Open AccessAtrial fibrillation-caused cerebral and splenic infarction: A case report
- Open Access
- 16 December 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (3)
Penetrating transorbital injury by a coloring pencil in a 3-year-old child: A case report
A transorbital penetrating injury by a foreign body is an extremely rare type of injury, and its severity is often difficult to estimate by examination of the superficial wound alone. Thus, such injuries are challenging for neurosurgeons to investigate and manage. We herein present a peculiar case involving a 3-year-old girl with a penetrating transorbital skull-base injury caused by a coloring pencil and discuss the anatomical location of the foreign body, radiological examination findings, diagnosis, and treatment strategy. The pencil was completely removed by manual extraction. Follow-up investigations confirmed a good outcome. Multidisciplinary cooperation, radiological examination, correct diagnosis, timely treatment, and detailed follow-up studies are necessary to manage penetrating transorbital skull-base injuries caused by foreign bodies. The orbital walls are very thin in children, and the orbital roof and superior orbital fissure are often penetrated by foreign bodies in cases such as that described herein. The anatomical location of the foreign body influences the clinical management strategy.
- 16 December 2019
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 48 (3)
Open AccessPenetrating transorbital injury by a coloring pencil in a 3-year-old child: A case report
A transorbital penetrating injury by a foreign body is an extremely rare type of injury, and its severity is often difficult to estimate by examination of the superficial wound alone. Thus, such injuries are challenging for neurosurgeons to investigate and manage. We herein present a peculiar case involving a 3-year-old girl with a penetrating transorbital skull-base injury caused by a coloring pencil and discuss the anatomical location of the foreign body, radiological examination findings, diagnosis, and treatment strategy. The pencil was completely removed by manual extraction. Follow-up investigations confirmed a good outcome. Multidisciplinary cooperation, radiological examination, correct diagnosis, timely treatment, and detailed follow-up studies are necessary to manage penetrating transorbital skull-base injuries caused by foreign bodies. The orbital walls are very thin in children, and the orbital roof and superior orbital fissure are often penetrated by foreign bodies in cases such as that described herein. The anatomical location of the foreign body influences the clinical management strategy.
- 26 February 2018
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 49 (2) , 209-218
miR-484/MAP2/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1/2 signaling
Glioma is the most common intracranial malignant tumor. Cancer stem cells (CSCs) are resistant to chemotherapy and radiotherapy, and are closely related to cancer metastasis and recurrence. In this study, we aimed to explore the effect of miR-484 on glioma stemness and the underlying mechanism involved. miR-484 enhanced glioma tumor-initiating properties in vitro and in vivo. Moreover, miR-484 was shown to directly target MAP2, resulting in activation of ERK1/2 signaling and promotion of stemness in glioma. The ERK1/2 signaling facilitated the formation of a miR-484/MAP2/c-Myc positive feedback loop in glioma. High miR-484 expression predicted a poor prognosis for glioma patients, and high MAP2 expression predicted a good prognosis for glioma patients. Low miR-484 expression and high MAP2 expression was associated with the best prognosis in glioma. Our study suggests that miR-484 and MAP2 can be utilized as predictors for the clinical diagnosis and prognosis of glioma, and miR-484 and MAP2 are potential targets for the treatment of glioma.
- 26 February 2018
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 49 (2) , 209-218
miR-484/MAP2/c-Myc-positive regulatory loop in glioma promotes tumor-initiating properties through ERK1/2 signaling
Glioma is the most common intracranial malignant tumor. Cancer stem cells (CSCs) are resistant to chemotherapy and radiotherapy, and are closely related to cancer metastasis and recurrence. In this study, we aimed to explore the effect of miR-484 on glioma stemness and the underlying mechanism involved. miR-484 enhanced glioma tumor-initiating properties in vitro and in vivo. Moreover, miR-484 was shown to directly target MAP2, resulting in activation of ERK1/2 signaling and promotion of stemness in glioma. The ERK1/2 signaling facilitated the formation of a miR-484/MAP2/c-Myc positive feedback loop in glioma. High miR-484 expression predicted a poor prognosis for glioma patients, and high MAP2 expression predicted a good prognosis for glioma patients. Low miR-484 expression and high MAP2 expression was associated with the best prognosis in glioma. Our study suggests that miR-484 and MAP2 can be utilized as predictors for the clinical diagnosis and prognosis of glioma, and miR-484 and MAP2 are potential targets for the treatment of glioma.